Angita Pharmaceuticals is dedicated to the discovery of novel targets and drug candidates for the treatment of unmet needs in diseases of the Central Nervous System (CNS) and indications in which the CNS plays an important function.
They have a number of projects ongoing and are constantly seeking to increase the diversity of our discovery portfolio through collaborative projects and in-licensing opportunities.
Angita Pharmaceuticals develops novel, patent-protected drug development candidates with strategic focus on CNS indications and those in which the CNS plays a clear regulatory function. They in-license novel IP from academia and adopt a flexible licensing model giving the inventor the opportunity to participate in the drug discovery projects. Other projects in their discovery pipeline come from in-house research activities and via joint projects with collaborative partners.To ensure focus on their discovery projects, development candidates will be out-licensed.
Angita Pharmaceutical is part of the Development, Testing & Analysis cluster of the Healthy Ageing Business Co-operative.
P.O. Box 2253
9704 CE Groningen
Tel: + 44 7917 725755
Fax: + 31 50 5757399